Clinical Trials Browser

Phase 2 × aflibercept × Plasma cell × Clear all

NCT00437034 2021-02-08

Aflibercept for Relapsed Multiple Myeloma

Phase 2 Terminated

6 enrolled 5 charts

Multiple Myeloma